Andrea L Schaffer1, Timothy A Dobbins2, Sallie-Anne Pearson3,4. 1. Centre for Big Data Research in Health, UNSW Sydney, Level 2, AGSM Building, Sydney, Australia. andrea.schaffer@unsw.edu.au. 2. School of Public Health and Community Medicine, UNSW Sydney, Sydney, Australia. 3. Centre for Big Data Research in Health, UNSW Sydney, Level 2, AGSM Building, Sydney, Australia. 4. Menzies Centre for Health Policy, University of Sydney, Sydney, Australia.
Abstract
BACKGROUND: Interrupted time series analysis is increasingly used to evaluate the impact of large-scale health interventions. While segmented regression is a common approach, it is not always adequate, especially in the presence of seasonality and autocorrelation. An Autoregressive Integrated Moving Average (ARIMA) model is an alternative method that can accommodate these issues. METHODS: We describe the underlying theory behind ARIMA models and how they can be used to evaluate population-level interventions, such as the introduction of health policies. We discuss how to select the shape of the impact, the model selection process, transfer functions, checking model fit, and interpretation of findings. We also provide R and SAS code to replicate our results. RESULTS: We illustrate ARIMA modelling using the example of a policy intervention to reduce inappropriate prescribing. In January 2014, the Australian government eliminated prescription refills for the 25 mg tablet strength of quetiapine, an antipsychotic, to deter its prescribing for non-approved indications. We examine the impact of this policy intervention on dispensing of quetiapine using dispensing claims data. CONCLUSIONS: ARIMA modelling is a useful tool to evaluate the impact of large-scale interventions when other approaches are not suitable, as it can account for underlying trends, autocorrelation and seasonality and allows for flexible modelling of different types of impacts.
BACKGROUND: Interrupted time series analysis is increasingly used to evaluate the impact of large-scale health interventions. While segmented regression is a common approach, it is not always adequate, especially in the presence of seasonality and autocorrelation. An Autoregressive Integrated Moving Average (ARIMA) model is an alternative method that can accommodate these issues. METHODS: We describe the underlying theory behind ARIMA models and how they can be used to evaluate population-level interventions, such as the introduction of health policies. We discuss how to select the shape of the impact, the model selection process, transfer functions, checking model fit, and interpretation of findings. We also provide R and SAS code to replicate our results. RESULTS: We illustrate ARIMA modelling using the example of a policy intervention to reduce inappropriate prescribing. In January 2014, the Australian government eliminated prescription refills for the 25 mg tablet strength of quetiapine, an antipsychotic, to deter its prescribing for non-approved indications. We examine the impact of this policy intervention on dispensing of quetiapine using dispensing claims data. CONCLUSIONS: ARIMA modelling is a useful tool to evaluate the impact of large-scale interventions when other approaches are not suitable, as it can account for underlying trends, autocorrelation and seasonality and allows for flexible modelling of different types of impacts.
Entities:
Keywords:
Autoregressive integrated moving average models; Interrupted time series analysis; Intervention analysis; Policy evaluation
Authors: Atle Fretheim; Fang Zhang; Dennis Ross-Degnan; Andrew D Oxman; Helen Cheyne; Robbie Foy; Steve Goodacre; Jeph Herrin; Ngaire Kerse; R James McKinlay; Adam Wright; Stephen B Soumerai Journal: J Clin Epidemiol Date: 2014-12-11 Impact factor: 6.437
Authors: Andrea L Schaffer; Nicholas A Buckley; Timothy A Dobbins; Emily Banks; Sallie-Anne Pearson Journal: Med J Aust Date: 2015-06-15 Impact factor: 7.738
Authors: Jonathan Brett; Andrea Schaffer; Timothy Dobbins; Nicholas A Buckley; Sallie-Anne Pearson Journal: Pharmacoepidemiol Drug Saf Date: 2018-02-28 Impact factor: 2.890
Authors: Andrea Schaffer; David Muscatello; Michelle Cretikos; Robin Gilmour; Sean Tobin; James Ward Journal: BMC Public Health Date: 2012-10-12 Impact factor: 3.295
Authors: Katie J Suda; Katherine Callaway Kim; Inmaculada Hernandez; Walid F Gellad; Scott Rothenberger; Allen Campbell; Lisa Malliart; Mina Tadrous Journal: J Am Pharm Assoc (2003) Date: 2021-12-24
Authors: Marie-Claude Pelland-Marcotte; Lin Xie; Randy Barber; Sulaf Elkhalifa; Mylene Frechette; Jaskiran Kaur; Jay Onysko; Eric Bouffet; Conrad V Fernandez; David Mitchell; Meera Rayar; Alicia Randall; David Stammers; Valérie Larouche; Alexandra Airhart; Miranda Fidler-Benaoudia; Sarah Cohen-Gogo; Lillian Sung; Paul Gibson Journal: CMAJ Date: 2021-11-29 Impact factor: 8.262